CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT)

CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT), returns to Stock Day to give details on Precision Oncology, tumor & drug testing, and growing via targeted therapies. NASDAQ: AIPT # formerly Skyline Medical: SKLN # FDA-approved STREAMWAY® System # Helomics Corporation # automated # breast cancer # Cytopatch # D-chip # FDA cleared # Lung cancer # medical devices # Ovarian cancer # patented # Precision Oncology # Tumor treatments # waste fluid management Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy